Advertisement

Topics

Novel Kinase Inhibitor OK'd for Follicular Lymphoma

09:47 EDT 14 Sep 2017 | MedPageToday

(MedPage Today) -- Copanlisib (Aliqopa) approved as third-line therapy

Original Article: Novel Kinase Inhibitor OK'd for Follicular Lymphoma

NEXT ARTICLE

More From BioPortfolio on "Novel Kinase Inhibitor OK'd for Follicular Lymphoma"

Quick Search
Advertisement